Loncar Cancer Immunotherapy ETF (CNCR) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with CNCR. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.
Cheapest Alternatives to CNCR
CNCR charges 0.79% annually. There are 52 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.08%.
| Symbol | Name | Expense Ratio | AUM | Inception | |
|---|---|---|---|---|---|
| State Street Health Care Select Sector SPDR ETF | 0.08% | 41.65B | Dec 1998 | CNCR vs XLV | |
| Fidelity MSCI Health Care Index ETF | 0.08% | 3.22B | Oct 2013 | CNCR vs FHLC | |
| Vanguard Health Care ETF | 0.09% | 19.00B | Jan 2004 | CNCR vs VHT | |
| Portfolio Building Block World Pharma and Biotech ... | 0.13% | 951.16M | Nov 2025 | CNCR vs PBPH | |
| Invesco Nasdaq Biotechnology ETF | 0.19% | 74.65M | Jun 2021 | CNCR vs IBBQ |
Best Risk-Adjusted Alternatives to CNCR
Among 56 ETFs in the Health & Biotech Equities category with risk / return rank data, the top risk-adjusted alternatives shown here go as high as 96.
| Symbol | Name | Risk / Return Rank | AUM | Inception | |
|---|---|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | 96 | 57.56M | Dec 2014 | CNCR vs BBC | |
| ALPS Medical Breakthroughs ETF | 94 | 213.08M | Dec 2014 | CNCR vs SBIO | |
| First Trust Nasdaq Pharmaceuticals ETF | 94 | 36.36M | Sep 2016 | CNCR vs FTXH | |
| iShares U.S. Pharmaceuticals ETF | 93 | 1.34B | May 2006 | CNCR vs IHE | |
| SPDR S&P Biotech ETF | 93 | 11.10B | Feb 2006 | CNCR vs XBI |
Top Performing CNCR Alternatives (YTD)
Among 63 ETFs in the Health & Biotech Equities category with YTD return data, the top-performing alternatives shown here go as high as 41.35%.
| Symbol | Name | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|
| AdvisorShares Psychedelics ETF | 41.35% | 44.37M | Sep 2021 | CNCR vs PSIL | |
| ARK Genomic Revolution Multi-Sector ETF | 38.38% | 1.31B | Oct 2014 | CNCR vs ARKG | |
| Roundhill UNH WeeklyPay ETF | 31.46% | 6.01M | Dec 2025 | CNCR vs UNHW | |
| Virtus LifeSci Biotech Clinical Trials ETF | 29.44% | 57.56M | Dec 2014 | CNCR vs BBC | |
| SPDR S&P Health Care Services ETF | 26.76% | 204.10M | Sep 2011 | CNCR vs XHS |
Lowest Volatility Alternatives to CNCR
CNCR has 0.00% 1-year volatility. No ETFs in the Health & Biotech Equities category have lower 1-year volatility; the lowest-volatility alternatives shown here go as low as 0.00%.
| Symbol | Name | Volatility 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| Amplify Treatments, Testing and Advancements ETF | 0.00% | 9.68M | Jun 2020 | CNCR vs GERM | |
| Horizon Kinetics SPAC Active ETF | 8.62% | 10.11M | Jun 2007 | CNCR vs SPAQ | |
| State Street Health Care Select Sector SPDR Premiu... | 11.06% | 16.78M | Jul 2025 | CNCR vs XLVI | |
| Milliman Healthcare Inflation Plus ETF | 11.54% | 982.35K | Apr 2026 | CNCR vs MHIP | |
| Global X Aging Population ETF | 14.11% | 85.65M | May 2016 | CNCR vs AGNG |
Lowest Drawdown Alternatives to CNCR
Among 57 ETFs in the Health & Biotech Equities category with 1-year drawdown data, the lowest-drawdown alternatives shown here go as shallow as 0.00%.
| Symbol | Name | Max Drawdown 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| Amplify Treatments, Testing and Advancements ETF | 0.00% | 9.68M | Jun 2020 | CNCR vs GERM | |
| Horizon Kinetics SPAC Active ETF | -4.32% | 10.11M | Jun 2007 | CNCR vs SPAQ | |
| First Trust Nasdaq Pharmaceuticals ETF | -7.47% | 36.36M | Sep 2016 | CNCR vs FTXH | |
| Invesco Nasdaq Biotechnology ETF | -8.34% | 74.65M | Jun 2021 | CNCR vs IBBQ | |
| iShares U.S. Pharmaceuticals ETF | -8.47% | 1.34B | May 2006 | CNCR vs IHE |
Other ETFs from Exchange Traded Concepts
The 10 most viewed Exchange Traded Concepts ETFs shown here include NUKZ, ROBO, CEFS and span 12 categories. AUM among these funds goes as high as $2B.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| Range Nuclear Renaissance ETF | Energy Equities | 16 | -1.21% | 832.38M | Jan 2024 | CNCR vs NUKZ | |
| ROBO Global Robotics & Automation Index ETF | Robotics, Technology Equities | 42 | 14.54% | 1.84B | Oct 2013 | CNCR vs ROBO | |
| Saba Closed-End Funds ETF | Event Driven, Actively Managed | 82 | 12.72% | 332.90M | Mar 2017 | CNCR vs CEFS | |
| High Yield ETF | High Yield Bonds | — | — | 95.91M | Nov 2010 | CNCR vs HYLD | |
| ROBO Global Artificial Intelligence ETF | Technology Equities | 68 | 33.28% | 451.01M | May 2020 | CNCR vs THNQ | |
| Hull Tactical US ETF | Long-Short | 75 | 11.11% | 137.43M | Jun 2015 | CNCR vs HTUS | |
| QRAFT AI-Enhanced U.S. Large Cap Momentum ETF | Momentum, Large Cap Growth Equities | 37 | 17.22% | 33.44M | May 2019 | CNCR vs AMOM | |
| EMQQ The Emerging Markets Internet ETF | Emerging Markets Equities | 4 | -17.06% | 273.19M | Nov 2014 | CNCR vs EMQQ | |
| Nifty India Financials ETF | Financials Equities | — | — | 10.83M | Oct 2020 | CNCR vs INDF | |
| ROBO Global Healthcare Technology and Innovation E... | Health & Biotech Equities | 60 | 8.68% | 49.62M | Jun 2019 | CNCR vs HTEC |
Often Compared With CNCR
Investors most often compare CNCR with SCHD, IYH, SMH. These 20 comparison targets span 10 categories, based on PortfoliosLab usage data.
Compare CNCR with Any Fund or Stock
Compare CNCR with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.
Pair CNCR with funds that move differently
Loncar Cancer Immunotherapy ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to CNCR.
Explore CNCR Diversifiers